Skip to main content
. 2018 Mar 21;9:127. doi: 10.3389/fneur.2018.00127

Figure 4.

Figure 4

Calculated HRs and 95% CIs for the relationship between methylation and OS benefit from TMZ-containing or TMZ-free therapy in newly diagnosed GBM patients (methylated vs. unmethylated patients).